The pioneering research of Prof. Michal Holčapek and his team at the University of Pardubice is now being tested on patients in a clinical setting.A clinical trial has begun in the Czech Republic to assess the effectiveness of an early detection test for pancreatic cancer. This trial will evaluate the sensitivity of a novel blood test designed to detect precancerous changes. If successful, this lipidomics-based test could revolutionise pancreatic cancer screening, offering a major advance in early diagnosis.The trial is a collaborative effort between Lipidica – a company jointly owned by the University of Pardubice and FONS JK Group – and specialists in gastroenterology and oncology. Lipidica will perform sample analyses for the clinical study. Key partners include the University Hospital Olomouc and the Masaryk Memorial Cancer Institute, with a total of 15 centres nationwide expected to participate.<blockquote><h4>Career: Postdoctoral Positions in Lipidomics and Glycomics</h4><ul><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/job/1713">more details and contacts</a></li></ul>You will be joining the dynamic Lipidomics Group at the University of Pardubice, working on high-impact research funded by prestigious grants:<ol><li>ERC Advanced grant “Oncolipidomics: Why is lipidomic dysregulation pattern in blood similar for various cancers? (ONCOLIPID)”</li><li>OP JAK grant “Saving lives through research in early cancer detection and prevention: Molecular, genomic and societal factors (SALVAGE)”</li></ol><h5>Two Postdoctoral Positions in Lipidomics and Glycomics</h5><ul><li>Start Date: January 2025 (or as soon as possible)</li><li>Duration: 12 months, with a possibility of extension until the end of the project (August 2028)</li><li>Location: Lipidomics Group of Prof. Michal Holčapek, University of Pardubice, Faculty of Chemical Technology, Department of Analytical Chemistry, Czech Republic</li><li>Salary: Competitive, based on university guidelines, and commensurate with experience and skills.</li></ul><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/University_of_Pardubice_University_of_Pardubice_254470ec4e.jpg" alt="University of Pardubice: University of Pardubice" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_University_of_Pardubice_University_of_Pardubice_254470ec4e.jpg 234w," sizes="100vw" width="1200" height="803"></blockquote>This methodology, which allows for early diagnosis, was developed by Prof. Michal Holčapek, a prominent analytical chemist and world-renowned expert in lipids at the University of Pardubice’s Faculty of Chemical Technology. Holčapek, a recipient of the prestigious European ERC Advanced grant, and his team achieved this breakthrough by analysing lipids in standard blood samples and applying advanced multivariate statistical analysis. "The lipidomics test is non-invasive and could pave the way for a structured screening programme,” explains Prof. Holčapek. "It may enable earlier detection of pancreatic cancer, where treatment success rates are higher and patient survival outcomes improve."This innovative method has been published in Nature Communications, one of the world’s leading scientific journals, and is protected by two patents held by the University of Pardubice.Experts from the Czech Gastroenterological Society (CGS) report that approximately 2 400 people are diagnosed with pancreatic cancer each year in the Czech Republic, and nearly 2 200 die from the disease within the same period. By 2030, experts project that pancreatic cancer will become the second leading cause of cancer deaths. "Pancreatic cancer is among the most aggressive forms of cancer – it develops asymptomatically over more than a decade but remains undetected until it is too advanced for effective treatment," says Prof. Ondřej Urban, M.D., Ph.D., Head of the Second Internal Gastroenterology and Geriatric Clinic at University Hospital Olomouc. "By the time symptoms appear, it is often too late for curative treatment, with surgery remaining the only potential cure, but only about 20% of patients qualify. The rest receive palliative care focused on extending life with as much quality as possible." For those with advanced pancreatic cancer, the average survival rate is about 1.5 years. However, patients diagnosed at an early stage can live up to six times longer. "We know that lipid profiles vary significantly in patients with pancreatic cancer," Prof. Urban adds. "This study aims to determine if the lipidomics test can detect these early lipid changes in high-risk individuals who feel healthy but may already have underlying disease."According to doc. MUDr. Jan Trna, Ph.D., Chief Physician of the Gastroenterology Department at the Masaryk Memorial Cancer Institute, the successful validation of the new lipidomics test would represent a major breakthrough in pancreatic cancer treatment. "Currently, our options for identifying individuals at risk for pancreatic cancer are limited. Due to financial, capacity, and medical constraints, specialised preventive testing cannot be offered to everyone. However, blood sampling presents a different approach. For decades, we have sought methods to detect the disease early – which is absolutely critical for this particular cancer," says MUDr. Trna. The Pancreatic Cancer Early Detection Programme now enables the identification of precancerous changes or early-stage cancer. Under this programme, gastroenterologists collaborate closely with clinical geneticists and radiologists who conduct specialised tests such as magnetic resonance imaging (MRI).Currently, the screening programme is available only to individuals with a lifetime risk of pancreatic cancer exceeding 5%. "In the newly established centres of highly specialised care for digestive endoscopy, including our department, at-risk individuals undergo regular pancreatic examinations using MRI and endoscopic ultrasonography," explains doc. MUDr. Ilja Tachecí, Ph.D., Chair of the CGS and Head of the Second Internal Gastroenterology Clinic at the Faculty of Medicine, Charles University in Hradec Králové. Individuals considered at risk include those with a hereditary form of chronic pancreatitis, those with two or more direct relatives diagnosed with pancreatic cancer, and carriers of specific genetic mutations – such as mutations in the BRCA1 and BRCA2 genes, which are also associated with breast and ovarian cancer."People at risk visit us for annual check-ups. As part of this study, we collect blood samples with their informed consent, which are then processed into plasma and sent to the Lipidica laboratory," explains Prof. Urban. The study thus analyses blood from both healthy high-risk individuals and patients with small, operable tumours. "Current diagnostic methods are highly effective but also costly and uncomfortable for patients. A test based on a simple blood draw would be a tremendous benefit for clinical practice. Our LDPC lipidomics test relies on a patent-protected methodology developed at the University of Pardubice, integrating insights from analytical chemistry, biostatistics, and other scientific disciplines," adds Ing. Karolína Kašparová, Director of Lipidica, which is also an accredited medical laboratory.Lipidica, a.s., a joint venture between the University of Pardubice and FONS JK Group a.s., has been <a target="_blank" rel="noopener noreferrer" href="https://www.upce.cz/en/neuron-awards-goes-to-lipidica-spin-off-of-the-university-of-pardubice">recognised with the Neuron Prize</a> for its exceptional bridging of science and business.The study began this year and is expected to conclude in 2027, involving over 400 participants. If the test's specificity and sensitivity are confirmed, experts note it may still take time before the test becomes a standard part of clinical care and before it is determined whether health insurers will cover it or if individuals will need to pay out of pocket. The manufacturer has indicated, however, that the price should not exceed a few thousand Czech korunas.&nbsp;

Clinical trial begins in Czech Republic to test groundbreaking pancreatic cancer detection method

<blockquote>Maciej Stopa1, 2; Rafał Szewczyk1, 2; Adrianna Radulska3, Anna Lenartowicz2; Julia Mironenka2; Adrian Soboń1, 2; Katarzyna Krupczyńska-Stopa1, 2; Tomasz Borkowski3; Ewelina Marciniak3, Leszek Kalinowski31<a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/companies/315">Bioanalytic</a> Sp. z o.o., Gdansk, Poland; 2LabExperts Sp. z o.o., Gdansk, Poland; 3 Medical University of Gdansk, Gdansk, Poland</blockquote><h4>Abstract</h4>Cardiac arrhythmia affects approximately 12.6% of people over the age of 65. Ventricular arrhythmias are considered as responsible for 75% to 80% of sudden cardiac deaths. Therapy of the disease include ablation, use of cardioverter or defibrillator and pharmacological treatment where the key for successful therapy lays in maintaining the necessary concentration of drugs. The goal can be achieved by therapeutic drug monitoring (TDM). Developed assay named “CardioCarePack” is based on the use of capillary blood collected and dried at home by a patient with volumetric absorptive microsampling (VAMS), quantitative analysis of selected drugs and their metabolites and a telemedical system that integrates all data between a doctor, patient and laboratory supporting the therapy process. CardioCarePack is ready for commercialization.<h4>Methods</h4>Blood collected with a <a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/products?distributorItems=315&amp;search=MITRA">MITRA® microsampling device</a> (20 µl) is prepared with full validated protocol that include sonication with 0.1% formic acid in water followed by acetonitrile extraction, evaporation under nitrogen stream and resuspension in LC mobile phase. Sample is subjected to LC-MS/MS analysis in positive ionization MRM mode with QTRAP 5500+ mass spectrometer (SCIEX) or similar one. Analysis covers simultaneous quantitation of 15 drugs: Sotalol, Metoprolol, Bisoprolol, Propafenone, Carvedilol, Nebivolol, Amiodarone, Digoxin, Perindopril, Ramipril, Eplerenone, Spironolactone, Zofenopril and 2 metabolites: 5-hydroxypropafenone and Desethylamiodarone. Results are placed in a server-based telemedical system where depending on accession rights history, doses, therapeutic index flagging, cardiograms, sample tracking and many other data are available for patient, doctor and laboratory staff, respectively.<h4>Preliminary Data</h4>The project involved more than 300 patients who had been monitored for 2 years during regular pharmacological therapy. Every half a year during a visit in medical facility venous blood for serum testing and capillary blood on the MITRA® sorbent were collected. Between the visits patients were collecting samples by VAMS themselves at home. All samples were analyzed by fully validated procedure where among the others linearity (r ≥ 0.995), accuracy (80 – 120%), reproducibility (%CV ≤ 15%) for both MITRA® and serum samples were calculated. The LC-MS/MS method developed for 17 compounds covers therapeutic range of the tested drugs: 0.25 – 25 ng/ml (Digoxin and Nebivolol) 2.5 – 250 ng/ml (Metoprolol, Bisoprolol, Propafenone, Carvedilol, Perindopril, Ramipril, Spironolactone, Zofenopril and 25 – 2500 ng/ml (Sotalol, Desethylamiodarone, Eplerenone, Amiodarone, 5-hydroxypropafenone). Results generated during LC-MS/MS analysis were analyzed with SCIEX OS 1.7 software.On the basis of samples collected during 4 visits in medical facility a correlation between drugs concentration in venous blood (serum) and capillary blood (MITRA®) (S/M) was calculated. For some compounds S/M ratio was close to 1 (ex. Sotalol – 0.95, %CV – 5.12%, Nebivolol – 1.03, %CV – 3.17%) or moderately to more than 2-fold different (ex. Digoxin – 0.69, %CV – 1.46%, Ramipril – 1.18, %CV – 11.1, Perindopril – 1.86, %CV – 4.73%, Amiodarone – 2.17, %CV – 10.78). The correlation factors are statistically significant (p &lt; 0.05) and can be used for accurate concentration estimation in venous blood.Developed telemedicine system integrate CardioCarePack service – a patient, doctor and LC-MS/MS laboratory. The system helps in Doctor’s supervision over the patient’s condition on the basis of collected within the system data ex.: autonomous verification of the therapeutic index with flagging, visualization of results, tracking samples on the patient-doctor line, schedule of visits, results history and many more.<h4>Novel aspect</h4>A modern telemedicine system for TDM of cardiological drugs based on LC-MS/MS analysis of samples collected at home with VAMS.

CardioCarePack – personalized medicine system to improve live quality of patients suffering from cardiac arrhythmias

In the week of January 13, the following webinars await you in the field of liquid phase and especially HPLC and LC/MS.<blockquote><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinars">👉 DETAILS AND REGISTRATION IN THE WEBINARS SECTION</a>👉 Search and filter in the largest global database with over 3 500 GC, LC, MS and spectroscopy webinars.</blockquote><h5>1. Waters Corporation: Light scattering-based solutions for excipients and advanced formulations</h5><div><div><ul><li><div>Tu, 14.1.2025 05:00 CET</div></li><li><div><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/4545">Registration</a></div></li></ul></div>In this webinar, we will showcase case studies demonstrating how SEC-MALS and FFF-MALS are utilized to characterize, quantify, and deformulate advanced excipients and formulations.</div><h5>2.&nbsp;Thermo Fisher Scientific: Well characterized biological products, challenging yet rewarding</h5><div><div><ul><li><div>Tu, 14.1.2025 11:00 CET</div></li><li><div><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/4578">Registration</a></div></li></ul></div>The presentation emphasizes the importance of developing innovative methods and technologies to support the ecosystem and enhance data workflows. It introduces the concept of a new facility, named "Concept".</div><h5>3.&nbsp;Agilent Technologies: Getting the Most from Your Agilent HPLC Pump</h5><div><div><ul><li><div>Tu, 14.1.2025 17:00 CET</div></li><li><div><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/4519">Registration</a></div></li></ul></div>We will focus on your Agilent HPLC pump. We will look at some of its capabilities and how to choose the right column for it. We will discuss best practices to help maximize up-time.</div><h5>4.&nbsp;Restek Corporation: Incorporating ultrashort-chain compounds into the comprehensive analysis of PFAS</h5><div><div><ul><li><div>We, 15.1.2025 17:00 CET</div></li><li><div><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/4569">Registration</a></div></li></ul></div>Join Dr. Shun-Hsin Liang, as he explores the simultaneous analysis of C1 to C14 PFCA and PFSA, along with other PFAS types, using two alternative chromatographic approaches.</div><h5>5.&nbsp;SCIEX: Unlocking precision: nitrosamine and NDSRI analysis</h5><div><div><ul><li><div>Th, 16.1.2025 10:30 CET</div></li><li><div><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/4682">Registration</a></div></li></ul></div>We invite you to join our webinar on nitrosamine and NDSRIs, specifically examining their analysis and implications in the pharmaceutical industry.</div><h5>6.&nbsp;Thermo Fisher Scientific: The merger of automated LC fractionation &amp; in-depth characterization</h5><div><div><ul><li><div>Th, 16.1.2025 11:00 CET</div></li><li><div><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/4579">Registration</a></div></li></ul></div>Dr. Kristensen discusses how the shift from traditional data handling methods to cloud solutions has revolutionized their workflow, enabling access to vast amounts of data from anywhere.</div><h5>7.&nbsp;Waters Corporation: Mastering the Quantitative Bioanalysis of Large Peptides and Proteins: A Case Study of GLP-1 Receptor Agonist Semaglutide in Plasma</h5><div><div><ul><li><div>Th, 16.1.2025 15:00 CEST</div></li><li><div><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/4384">Registration</a></div></li></ul></div>We present new data demonstrating a comprehensive and streamlined approach to optimized LC-MS/MS quantification of peptides, addressing the common challenges.</div><h5>8.&nbsp;Waters Corporation: Method Validation</h5><div><div><ul><li><div>Th, 16.1.2025 19:00 CET</div></li><li><div><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/4669">Registration</a></div></li></ul></div>We´ll discuss practical guidance around accuracy, precision, limit of quantitation and limit of detection and next we´ll walk you through an Empower CDS tool.</div>

Webinars LabRulezLCMS Week 3/2025

Article

Product

Webinars

Poster

Health

Science and research

Modern - Dynamic - With Tradition
Seven faculties, 7,000 students. Well-equipped classrooms and laboratories, top scientific teams and institutional accreditation is key fields. Chemists and economists, philosophers and historians, health professionals, transport experts, electrical engineers and computer scientists, and restorers study here. According to international ratings, we are one of the best universities in the Czech Republic.

Univerzita Pardubice

Everything from the world of analytical chemistry in one place. We connect people in solving their problems. At Labrulez you will find all the necessary information easily, quickly and clearly. Stop searching and start finding.

LabRulez

Bioanalytic started its operations in 1998. The company was born from a passion for science and the need to provide innovative solutions in the laboratory equipment market, from a small business to a dynamically developing company with an established position.

Bioanalytic

Watrex SCI-AQUA ROWAPUR BASIC Water Purification System

Fully automatic system for the preparation of pure water based on reverse osmosis. Reverse osmosis membrane is protected by three-stage pre-filtration consisting of sediment filter and two carbon adsorption filters.

Fully automatic system for the preparation of pure water based on reverse osmosis. Reverse osmosis membrane is protected by three-stage pre-filtration consisting of sediment filter and two carbon adsorption filters.Watrex SCI-AQUA BASIC is driven by water pressure from water distribution network, it does not require electric power. It prepares water free of mechanical impurities, chlorine, 95-99% of all dissolved substances are removed.&nbsp;Depending on input water composition and supply pressure the output water has a specific conductivity in the range of 10-20 µS/cm.Price: <bdi>384&nbsp;€</bdi> ex. VAT<h4>Features</h4><ul><li>Removes 95 – 99% of dissolved substances</li><li>Typical specific conductivity of produced water 10 – 20 µS/cm</li><li>6 to 12 months filters lifetime</li><li>2 – 5 years RO membrane lifetime</li><li>No electricity is required for operation</li><li>Supplied from water distribution network</li></ul><h4>Technical specification</h4><ul><li>Daily production capacity: 50 – 70 liters</li><li>Input water pressure: 0,3 – 0,7 MPa</li><li>Input water temperature: &lt; 35 °C</li><li>Maximum input water TDS: 1200 mg/l</li></ul><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Watrex_Water_purification_systems_8810a2c48a.jpg" alt="Watrex: Water purification systems" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Watrex_Water_purification_systems_8810a2c48a.jpg 245w," sizes="100vw" width="2286" height="1130">Basic requirements for laboratory operations include the easy availability of pure laboratory water in the necessary quantity and quality. Distillation, a popular technique for producing purified water in the past, has virtually completely supplanted by less energy-intensive and operationally dependable alternatives today. Reverse osmosis is the foundation of the majority of contemporary systems for producing purified water; in reality, this principle is supplemented with adsorption, ion exchange, filtration, ultrafiltration, and other physical-chemical techniques.

Watrex SCI-AQUA ROWAPUR DEMI 90 Water Purification System

Fully automatic system for the preparation of clean water based on reverse osmosis combined with purification by a mixed ion exchanger.

Fully automatic system for the preparation of clean water based on reverse osmosis combined with purification by a mixed ion exchanger. Reverse osmosis membrane is protected by two-stage pre-filtration consisting of sediment and carbon filter.Watrex ROWAPUR DEMI is driven by water pressure from water distribution network, it does not require electric power.The output water has a specific conductivity less than &lt;1 µS/cm. The system includes a conductivity tester with optical indication of output water quality.Price: <bdi>761 €</bdi> ex. VAT<h4>Features</h4><ul><li>Specific conductivity of produced water &lt;1 µS/cm</li><li>6 to 12 months filters lifetime</li><li>2 – 5 years RO membrane lifetime</li><li>1000 – 2000 liters polishing filter capacity</li><li>No electricity is required for operation</li><li>Supplied from water distribution network</li></ul><h4>Technical specification</h4><ul><li>Specific conductivity of produced water: &lt; 1 µS/cm</li><li>Daily production capacity:&nbsp;up to 90 liters</li><li>Input water pressure:&nbsp;0,3 – 0,7 MPa</li><li>Input water temperature:&nbsp;&lt; 35 °C</li><li>Maximum input water TDS:&nbsp;1200 mg/l</li></ul><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Watrex_Water_purification_systems_8810a2c48a.jpg" alt="Watrex: Water purification systems" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Watrex_Water_purification_systems_8810a2c48a.jpg 245w," sizes="100vw" width="2286" height="1130">Basic requirements for laboratory operations include the easy availability of pure laboratory water in the necessary quantity and quality. Distillation, a popular technique for producing purified water in the past, has virtually completely supplanted by less energy-intensive and operationally dependable alternatives today. Reverse osmosis is the foundation of the majority of contemporary systems for producing purified water; in reality, this principle is supplemented with adsorption, ion exchange, filtration, ultrafiltration, and other physical-chemical techniques.

Watrex SCI-AQUA ROWAPUR DEMI 180 Water Purification System

Fully automatic system for the preparation of clean water based on reverse osmosis combined with purification by a mixed ion exchanger. Reverse osmosis membrane is protected by two-stage pre-filtration consisting of sediment and carbon filter.Watrex ROWAPUR DEMI is driven by water pressure from water distribution network, it does not require electric power.The output water has a specific conductivity less than &lt;1 µS/cm. The system includes a conductivity tester with optical indication of output water quality.Price: 833<bdi> €</bdi> ex. VAT<h4>Features</h4><ul><li>Specific conductivity of produced water &lt;1 µS/cm</li><li>6 to 12 months filters lifetime</li><li>2 – 5 years RO membrane lifetime</li><li>1000 – 2000 liters polishing filter capacity</li><li>No electricity is required for operation</li><li>Supplied from water distribution network</li></ul><h4>Technical specification</h4><ul><li>Specific conductivity of produced water: &lt; 1 µS/cm</li><li>Daily production capacity:&nbsp;up to 180 liters</li><li>Input water pressure:&nbsp;0,3 – 0,7 MPa</li><li>Input water temperature:&nbsp;&lt; 35 °C</li><li>Maximum input water TDS:&nbsp;1200 mg/l</li></ul><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Watrex_Water_purification_systems_8810a2c48a.jpg" alt="Watrex: Water purification systems" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Watrex_Water_purification_systems_8810a2c48a.jpg 245w," sizes="100vw" width="2286" height="1130">Basic requirements for laboratory operations include the easy availability of pure laboratory water in the necessary quantity and quality. Distillation, a popular technique for producing purified water in the past, has virtually completely supplanted by less energy-intensive and operationally dependable alternatives today. Reverse osmosis is the foundation of the majority of contemporary systems for producing purified water; in reality, this principle is supplemented with adsorption, ion exchange, filtration, ultrafiltration, and other physical-chemical techniques.

Watrex SCI-AQUA ROWAPUR 090 Water Purification System

Fully automatic system for the preparation of pure water based on reverse osmosis.

Fully automatic system for the preparation of pure water based on reverse osmosis. Reverse osmosis membrane is protected by three-stage pre-filtration consisting of sediment filter and two carbon adsorption filters.Watrex ROWAPUR is driven by water pressure from water distribution network, it does not require electric power.It prepares water free of mechanical impurities, chlorine, 95-99% of all dissolved substances are removed. Depending on input water composition and supply pressure the output water has a specific conductivity in the range of 10-20 µS/cm.Price: 500<bdi>&nbsp;€</bdi> ex. VAT<h4>Features</h4><ul><li>Removes 95 – 99% of dissolved substances</li><li>Typical specific conductivity of produced water 10 – 20 µS/cm</li><li>6 to 12 months filters lifetime</li><li>2 – 5 years RO membrane lifetime</li><li>No electricity is required for operation</li><li>Supplied from water distribution network</li></ul><h4>Technical specification</h4><ul><li>Daily production capacity:&nbsp;up to 90 liters</li><li>Input water pressure:&nbsp;0,3 – 0,7 MPa</li><li>Input water temperature:&nbsp;&lt; 35 °C</li><li>Maximum input water TDS: 1200 mg/l</li></ul><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Watrex_Water_purification_systems_8810a2c48a.jpg" alt="Watrex: Water purification systems" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Watrex_Water_purification_systems_8810a2c48a.jpg 245w," sizes="100vw" width="2286" height="1130">Basic requirements for laboratory operations include the easy availability of pure laboratory water in the necessary quantity and quality. Distillation, a popular technique for producing purified water in the past, has virtually completely supplanted by less energy-intensive and operationally dependable alternatives today. Reverse osmosis is the foundation of the majority of contemporary systems for producing purified water; in reality, this principle is supplemented with adsorption, ion exchange, filtration, ultrafiltration, and other physical-chemical techniques.

Watrex SCI-AQUA ROWAPUR 180 Water Purification System

Fully automatic system for the preparation of pure water based on reverse osmosis. Reverse osmosis membrane is protected by three-stage pre-filtration consisting of sediment filter and two carbon adsorption filters.Watrex ROWAPUR is driven by water pressure from water distribution network, it does not require electric power.It prepares water free of mechanical impurities, chlorine, 95-99% of all dissolved substances are removed. Depending on input water composition and supply pressure the output water has a specific conductivity in the range of 10-20 µS/cm.Price: 541<bdi>&nbsp;€</bdi> ex. VAT<h4>Features</h4><ul><li>Removes 95 – 99% of dissolved substances</li><li>Typical specific conductivity of produced water 10 – 20 µS/cm</li><li>6 to 12 months filters lifetime</li><li>2 – 5 years RO membrane lifetime</li><li>No electricity is required for operation</li><li>Supplied from water distribution network</li></ul><h4>Technical specification</h4><ul><li>Daily production capacity:&nbsp;up to 180 liters</li><li>Input water pressure:&nbsp;0,3 – 0,7 MPa</li><li>Input water temperature:&nbsp;&lt; 35 °C</li><li>Maximum input water TDS: 1200 mg/l</li></ul><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Watrex_Water_purification_systems_8810a2c48a.jpg" alt="Watrex: Water purification systems" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Watrex_Water_purification_systems_8810a2c48a.jpg 245w," sizes="100vw" width="2286" height="1130">Basic requirements for laboratory operations include the easy availability of pure laboratory water in the necessary quantity and quality. Distillation, a popular technique for producing purified water in the past, has virtually completely supplanted by less energy-intensive and operationally dependable alternatives today. Reverse osmosis is the foundation of the majority of contemporary systems for producing purified water; in reality, this principle is supplemented with adsorption, ion exchange, filtration, ultrafiltration, and other physical-chemical techniques.

Watrex SCI-AQUA ROWAPUR 270 Water Purification System

Fully automatic system for the preparation of pure water based on reverse osmosis. Reverse osmosis membrane is protected by three-stage pre-filtration consisting of sediment filter and two carbon adsorption filters.Watrex ROWAPUR is driven by water pressure from water distribution network, it does not require electric power.It prepares water free of mechanical impurities, chlorine, 95-99% of all dissolved substances are removed. Depending on input water composition and supply pressure the output water has a specific conductivity in the range of 10-20 µS/cm.Price: 592<bdi>&nbsp;€</bdi> ex. VAT<h4>Features</h4><ul><li>Removes 95 – 99% of dissolved substances</li><li>Typical specific conductivity of produced water 10 – 20 µS/cm</li><li>6 to 12 months filters lifetime</li><li>2 – 5 years RO membrane lifetime</li><li>No electricity is required for operation</li><li>Supplied from water distribution network</li></ul><h4>Technical specification</h4><ul><li>Daily production capacity:&nbsp;up to 270 liters</li><li>Input water pressure:&nbsp;0,3 – 0,7 MPa</li><li>Input water temperature:&nbsp;&lt; 35 °C</li><li>Maximum input water TDS: 1200 mg/l</li></ul><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Watrex_Water_purification_systems_8810a2c48a.jpg" alt="Watrex: Water purification systems" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Watrex_Water_purification_systems_8810a2c48a.jpg 245w," sizes="100vw" width="2286" height="1130">Basic requirements for laboratory operations include the easy availability of pure laboratory water in the necessary quantity and quality. Distillation, a popular technique for producing purified water in the past, has virtually completely supplanted by less energy-intensive and operationally dependable alternatives today. Reverse osmosis is the foundation of the majority of contemporary systems for producing purified water; in reality, this principle is supplemented with adsorption, ion exchange, filtration, ultrafiltration, and other physical-chemical techniques.

Watrex SCI-AQUA ULTRAPUR Water Purification System

WATREX ULTRAPURE is dedicated to preparaton of ultrapure water for analytical, biochemical and other laboratories.

WATREX ULTRAPURE is dedicated to preparaton of ultrapure water for analytical, biochemical and other laboratories where the water with specific conductivity values below 0.1 µS/cm and a TOC value of less than 50 ppb is required.The device is fed with pressurized pre-treated water, preferably with conductivity values below 15 µS/cm (e.g. water treated by reverse osmosis).Watrex ULTRAPUR is supplied with a digital flow conductometer that allows monitoring the proper functioning of the device and the need to replace exhausted filter cartridges.The water treated by ULTRAPURE system is suitable for HPLC, AA, ICP and other demanding analyses.The maintenance of the device is very simple and consists only in replacing the filter inserts after they are exhausted.Price: 923<bdi>&nbsp;€</bdi> ex. VAT<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Watrex_Water_purification_systems_8810a2c48a.jpg" alt="Watrex: Water purification systems" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Watrex_Water_purification_systems_8810a2c48a.jpg 245w," sizes="100vw" width="2286" height="1130">Basic requirements for laboratory operations include the easy availability of pure laboratory water in the necessary quantity and quality. Distillation, a popular technique for producing purified water in the past, has virtually completely supplanted by less energy-intensive and operationally dependable alternatives today. Reverse osmosis is the foundation of the majority of contemporary systems for producing purified water; in reality, this principle is supplemented with adsorption, ion exchange, filtration, ultrafiltration, and other physical-chemical techniques.

Products from category Laboratory equipment | LabRulez LCMS

Related content

Webinars LabRulezLCMS Week 3/2025

Clinical trial begins in Czech Republic to test groundbreaking pancreatic cancer detection method

CardioCarePack – personalized medicine system to improve live quality of patients suffering from cardiac arrhythmias